Comparative Effectiveness Conflicts

I forgot to mention (because it's beaten into the mainstream mindset that only free market thinkers can be "conflicted")) that the comparative effectiveness crowd has some conflicts of their own, starting with the fact that they are funded by insurance companies. But I guess taking money from organizations that switch people from one molocule to another without telling patients is okay for bloggers like Health Care Renewal. The science linking statin response to genetic mutation is pretty compelling -- but maybe HCR wants to challenge the science in this area too?

Then there is the trial attorney/Soros/Avorn connection that is never disclosed. Drugwonks posted on that previously.

http://drugwonks.com/2007/02/iom_safety_committee_conflicted_and_confused.html